Key facts
- This page summarizes Shameze Rampertab's Form 4 filing for ASENSUS SURGICAL, INC..
- 11 reported transactions and 9 derivative rows are listed below.
- Accepted by SEC: 06 Feb 2024, 19:01.
Shameze Rampertab - 04 Feb 2024 Form 4 Insider Report for ASENSUS SURGICAL, INC.
- Reporting relationship
- EVP, Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 04 Feb 2024
- Net transaction value
- -$40,599
- SEC form
- 4
- Accepted by SEC
- 06 Feb 2024, 19:01:47 UTC
- Prior SEC filing
- 05 Jul 2023
- Next SEC filing
- 23 Apr 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Joshua Weingard as attorney-in-fact for Shameze Rampertab
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Shameze Rampertab filed Form 4 for ASENSUS SURGICAL, INC. on 06 Feb 2024.
Change
- Previous filing in this sequence was filed on 05 Jul 2023.
- Current net transaction value: -$40,599.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
ASXC
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +280,909
- Change %
- +113%
- Price
- $0.000000
- Shares after
- 528,772
- Date
- 04 Feb 2024
- Ownership
- Direct
ASXC
transaction
Common Stock
Tax liability
- Transaction value
- $40,599
- Shares
- -150,367
- Change %
- -28%
- Price
- $0.2700
- Shares after
- 378,405
- Date
- 04 Feb 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
ASXC
transaction
Derivative
Stock Options
Award
- Transaction value
- $0
- Shares
- +396,800
- Change %
- Price
- $0.000000
- Shares after
- 396,800
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 396,800
- Exercise price
- $0.2600
- Footnotes
- F2
ASXC
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +660,600
- Change %
- Price
- $0.000000
- Shares after
- 660,600
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 660,600
- Exercise price
- $0.000000
- Footnotes
- F3, F4
ASXC
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +330,300
- Change %
- Price
- $0.000000
- Shares after
- 330,300
- Date
- 06 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 330,300
- Exercise price
- $0.000000
- Footnotes
- F5, F6
ASXC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -19,704
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,704
- Exercise price
- $0.000000
- Footnotes
- F3, F7
ASXC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -19,704
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 04 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 19,704
- Exercise price
- $0.000000
- Footnotes
- F5, F8
ASXC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -62,417
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 62,417
- Date
- 04 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,417
- Exercise price
- $0.000000
- Footnotes
- F3, F9
ASXC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -62,417
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 62,417
- Date
- 04 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 62,417
- Exercise price
- $0.000000
- Footnotes
- F5, F10
ASXC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -58,334
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 116,666
- Date
- 04 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 58,334
- Exercise price
- $0.000000
- Footnotes
- F3, F11
ASXC
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -58,333
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 116,667
- Date
- 04 Feb 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 58,333
- Exercise price
- $0.000000
- Footnotes
- F5, F12
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 12 footnotes
Footnote F1
This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
Footnote F2
Vests one-third annually on each of February 6, 2025, 2026 and 2027, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement").
Footnote F3
Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
Footnote F4
Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2025, 2026 and 2027, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement.
Footnote F5
Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.
Footnote F6
PRSU award with time-based vesting in three equal installments on each of February 4, 2025, 2026 and 2027, and performance-based vesting only if designated corporate goals are met.
Footnote F7
Lapse of forfeiture on third one-third of an award of RSUs from a grant made on February 8, 2021.
Footnote F8
Lapse of forfeiture restrictions on third one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals.
Footnote F9
Lapse of forfeiture restrictions on the second one-third of a RSU award granted on February 4, 2022. Forfeiture restrictions will lapse on the remaining RSUs on February 4, 2025, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
Footnote F10
Lapse of forfeiture restrictions on the second one-third of a PRSU award granted on February 4, 2022 upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs on February 4, 2025, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
Footnote F11
Lapse of forfeiture restrictions on one-third of a RSU award granted on February 3, 2023. Forfeiture restrictions will lapse on the remaining RSUs on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan and teh Reporting Person's Employment Agreement.
Footnote F12
Lapse of forfeiture restrictions on the first one-third of one-half of a PRSU award granted on February 3, 2023. One-half of the PRSUs were forfeited upon failure to achieve one of two performance goals. The remaining earned PRSUs will vest on each of February 4, 2025 and 2026, as long as the Reporting Person provides continuous service to the Company during the vesting period and subject to acceleration as set forth in the Registrant's Plan ad the Reporting Person's Employment Agreement.